Efficacy of Ultrasound-guided Axillary Nerve Block Versus Ultrasound-guided Peripheral Forearm Block in Patients Undergoing Hand Surgery
1 other identifier
interventional
80
1 country
1
Brief Summary
By means of an observer-blinded, mono-center, prospective, randomized controlled superiority trial, the total anesthesia-related time (sum of performance and onset times) of an ultrasound-guided distal peripheral nerve block and an ultrasound-guided axillary nerve block will be investigated in patients undergoing hand surgery. The hypothesis is that the onset-time of the ultrasound-guided distal peripheral nerve block will be faster than ultrasound-guided axillary nerve blocks, which is more suitable for hand surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable surgery
Started Jan 2021
Shorter than P25 for not_applicable surgery
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2020
CompletedFirst Posted
Study publicly available on registry
December 22, 2020
CompletedStudy Start
First participant enrolled
January 13, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2021
CompletedNovember 19, 2021
November 1, 2021
9 months
November 30, 2020
November 18, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Total anaesthesia-related time
The total anesthesia-related time is the sum of block performance time and onset time of the block. Block performance time is defined as the time interval between the start of the block procedure and the end of the block procedure, thus imaging + needling time. Block performance time will be recorded with a stopwatch by the attending block room nurse. Time for the sensory block to take effect is defined as the time required for the limb to achieve a level of anesthesia deemed adequate for surgery (i.e., not necessarily a complete block) after placement of the block.
Preoperative
Secondary Outcomes (18)
Surgical block success rate
Intraoperative
Patient satisfaction
Day 0 and day 1 postoperatively
Needling time
Preoperative
Surgical time
Intraoperative
Total OR stay time
Intraoperative
- +13 more secondary outcomes
Study Arms (2)
Ultrasound-guided distal peripheral nerve block
ACTIVE COMPARATORPatients will receive the ultrasound-guided distal peripheral nerve block (locoregional anesthesia)
Ultrasound-guided quadruple-injection axillary nerve block
EXPERIMENTALPatients will receive the ultrasound-guided quadruple-injection axillary nerve block (locoregional anesthesia)
Interventions
To localize the median nerve, the ultrasound transducer will be placed in a transverse orientation proximally to the wrist cease at mid-forearm level, with a slight tilt distally towards the hand. An in-plane ultrasound-guided medial-to-lateral puncture will be made and 3ml of 2% lidocaine was injected within the fascia that envelopes the median nerve. To perform the ulnar block, an ultrasound transducer will be placed in a transverse orientation over the ulnar side of the distal forearm. An in-plane ultrasound-guided medial-to-lateral or proximal-to distal puncture will be made and 3 ml of 2% lidocaine will be infiltrated into the fascial plane to block the ulnar nerve. Finally, we will apply a circumferential subcutaneous infiltration of 4 ml 2% lidocaine at the radial side of the wrist, 2cm proximal to the styloid process of the radius to block the terminal sensory branches of the radial, musculocutaneous, and medial antebrachial cutaneous nerves that may reach the palmar crease.
The US probe will be applied in the axilla to obtain a short-axis view of the axillary artery. The following 4 nerves will be identified as hyperechoic structures: the median, ulnar, and radial nerve surrounding the axillary artery and the musculocutaneous nerve in the fascial layers between the biceps and coracobrachialis muscles. A total volume of 20 mL lidocaine 2% will be administered divided over 4 locations. The needle is inserted in-plane from the anterior aspect of the axillary artery and directed toward the posterior aspect of the axillary artery to first anesthetize the radial nerve. The posteriorly located radial nerve is surrounded with 8 mL of local anesthetic. Afterward, the needle is withdrawn and redirected to the median and ulnar nerves, after which another 8 mL of local anesthetic is deposited. In the end, the needle is withdrawn and redirected toward the musculocutaneous nerve where another 4 mL of local anesthetic is deposited.
Eligibility Criteria
You may qualify if:
- ≥18 years old
- ASA (American Society of Anesthesiology) classification: 1 - 3
- Scheduled for surgery in the day surgery unit
- Patients planned for unilateral hand surgery: carpal tunnel release, finger amputation (except digit I and II), finger manipulation (except digit I and II), hand foreign body removal (except digit I and II), hand incision and drainage, metacarpal fracture repair (except digit I and II), trigger finger release (except digit I), tendon repair (except digit I), and Dupuytren's contracture (except digit I)
You may not qualify if:
- Refusal of the patient
- Bilateral surgery
- BMI ≥ 40 kg/m²
- Puncture site infections
- Preexisting peripheral neuropathy
- Chronic pain syndrome
- Diabetes mellitus
- Pregnancy
- Use of strong pain medication in the past 3 months
- Allergy for any of the medications used
- Coagulation disorders or the use of anticoagulant therapy (vitamin K antagonists, new oral anticoagulants) or antiplatelet drugs (thienopyridines)
- Contra-indication for the use of a tourniquet
- Previous surgery in the same upper extremity
- Impossibility to understand the study protocol
- Not understanding the Dutch language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jessa Hospitallead
Study Sites (1)
Jessa Hospital
Hasselt, Limburg, Belgium
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 30, 2020
First Posted
December 22, 2020
Study Start
January 13, 2021
Primary Completion
October 8, 2021
Study Completion
October 31, 2021
Last Updated
November 19, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share